BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 5020429)

  • 1. Analysis of HL-A antigens in patients with Hodgkin's disease and their families.
    Forbes JF; Morris PJ
    J Clin Invest; 1972 May; 51(5):1156-63. PubMed ID: 5020429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HL-A antigens in patients with Hodgkin's disease].
    Maczyńska-Rusiniak B; Zupańska B
    Acta Haematol Pol; 1975; 6(4):267-71. PubMed ID: 1199675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MHC related genetic susceptibility to Hodgkin's disease.
    Kalidi I; Masset M; Gony J; Marcelli A; Jeannet M; Irlé C; Bauters F; Tchernia G; Turpin F; Gisselbrecht C
    Nouv Rev Fr Hematol (1978); 1989; 31(2):149-52. PubMed ID: 2771630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic factors in Hodgkin's disease: association with a disease-susceptibility locus (DSA) in the HL-A region.
    Bodmer WF
    Natl Cancer Inst Monogr; 1973 May; 36():127-34. PubMed ID: 4744574
    [No Abstract]   [Full Text] [Related]  

  • 5. HL-A histocompatibility antigens and their relation to disease.
    Lange CF
    Prog Clin Pathol; 1975; 6():137-62. PubMed ID: 1105669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hl-A antigens associated with rheumatoid arthritis and ankylosing spondylitis in an ethnic homogeneous population.
    Marcolongo R; Contu L
    Biomedicine; 1975 Apr; 23(3):88-91. PubMed ID: 1222227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etiological heterogeneity in Hodgkin's disease: HLA linked and unlinked determinants of susceptibility independent of histological concordance.
    Chakravarti A; Halloran SL; Bale SJ; Tucker MA
    Genet Epidemiol; 1986; 3(6):407-15. PubMed ID: 3803911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
    Kuljić-Kapulica N
    Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of HLA antigens in patients with Hodgkin's disease.
    Prazák J; Hermanská Z
    Eur J Haematol; 1989 Jul; 43(1):50-3. PubMed ID: 2788584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HL-A antigens in Hodgkin's disease and other lymphomas.
    Sybesma JP; Borst-Eilers E; Holtzer JD; Moes M; Pielage E; De Planque BA
    Vox Sang; 1972; 22(4):319-24. PubMed ID: 4553478
    [No Abstract]   [Full Text] [Related]  

  • 11. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human leukocyte antigen class I region is associated with EBV-positive Hodgkin's lymphoma: HLA-A and HLA complex group 9 are putative candidate genes.
    Niens M; van den Berg A; Diepstra A; Nolte IM; van der Steege G; Gallagher A; Taylor GM; Jarrett RF; Poppema S; te Meerman GJ
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2280-4. PubMed ID: 17119058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
    Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
    Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
    Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
    J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and expression of CT45 in Hodgkin's lymphoma.
    Heidebrecht HJ; Claviez A; Kruse ML; Pollmann M; Buck F; Harder S; Tiemann M; Dörffel W; Parwaresch R
    Clin Cancer Res; 2006 Aug; 12(16):4804-11. PubMed ID: 16914565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between glutathione S-transferase genotypes and Hodgkin's lymphoma risk and prognosis.
    Hohaus S; Massini G; D'Alo' F; Guidi F; Putzulu R; Scardocci A; Rabi A; Di Febo AL; Voso MT; Leone G
    Clin Cancer Res; 2003 Aug; 9(9):3435-40. PubMed ID: 12960134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-associated Hodgkin's lymphoma.
    Gandhi MK; Tellam JT; Khanna R
    Br J Haematol; 2004 May; 125(3):267-81. PubMed ID: 15086409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationships between Epstein-Barr virus latent membrane protein 1 and regulatory T cells in Hodgkin's lymphoma.
    Marshall NA; Culligan DJ; Tighe J; Johnston PW; Barker RN; Vickers MA
    Exp Hematol; 2007 Apr; 35(4):596-604. PubMed ID: 17379070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HLA system antigens in Hodgkin's disease in children].
    Vuković I; Susaković N; Dujić A; Stojimirović E; Marković V
    Bilt Hematol Transfuz; 1977; 5(3-4):59-65. PubMed ID: 615611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hodgkin's lymphoma in systemic lupus erythematosus.
    Bernatsky S; Ramsey-Goldman R; Isenberg D; Rahman A; Dooley MA; Sibley J; Boivin JF; Joseph L; Armitage J; Zoma A; Clarke A
    Rheumatology (Oxford); 2007 May; 46(5):830-2. PubMed ID: 17255135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.